107 related articles for article (PubMed ID: 17169375)
61. Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis.
Kawajiri M; Mogi M; Osoegawa M; Matsuoka T; Tsukuda K; Kohara K; Horiuchi M; Miki T; Kira JI
Mult Scler; 2008 May; 14(4):557-60. PubMed ID: 18562510
[TBL] [Abstract][Full Text] [Related]
62. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
[TBL] [Abstract][Full Text] [Related]
63. Detection of apoptotic cells in cerebrospinal fluid of patients suffering from neurological disease.
Goertsches R; Knappe S; Mix E; Zettl UK
J Neuroimmunol; 2007 Aug; 188(1-2):175-80. PubMed ID: 17602757
[TBL] [Abstract][Full Text] [Related]
64. Steroid hormones in multiple sclerosis.
El-Etr M; Vukusic S; Gignoux L; Durand-Dubief F; Achiti I; Baulieu EE; Confavreux C
J Neurol Sci; 2005 Jun; 233(1-2):49-54. PubMed ID: 15878598
[TBL] [Abstract][Full Text] [Related]
65. Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity.
Patas K; Engler JB; Friese MA; Gold SM
J Reprod Immunol; 2013 Mar; 97(1):140-6. PubMed ID: 23432880
[TBL] [Abstract][Full Text] [Related]
66. Proapoptotic CD95L levels in normal human serum and sera of breast cancer patients.
Olimón-Andalón V; Aguilar-Lemarroy A; Ratkovich-González S; Uribe-López A; Mariscal-Ramírez I; Delgadillo-Cristerna R; Ortiz-Lazareno P; Hernández-Flores G; de Celis R; Bravo-Cuellar A; Jave-Suárez LF
Tumour Biol; 2015 May; 36(5):3669-78. PubMed ID: 25557789
[TBL] [Abstract][Full Text] [Related]
67. Serum sAPO-1/Fas levels in multiple sclerosis.
Bansil S; Holtz CR; Cook SD; Rohowsky-Kochan C
Acta Neurol Scand; 1997 Apr; 95(4):208-10. PubMed ID: 9150810
[TBL] [Abstract][Full Text] [Related]
68. [Debatable questions concerning the problem of multiple sclerosis].
Umanskiĭ KG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):192-8. PubMed ID: 3577505
[TBL] [Abstract][Full Text] [Related]
69. [The levels of soluble CD95 antigen and CD95+ mononuclear cells in patients with chronic obstructive lung diseases].
Kubysheva NI; Postnikova LB; Presniakova NB; Novikov VV
Klin Lab Diagn; 2009 Mar; (3):22-3. PubMed ID: 19391241
[TBL] [Abstract][Full Text] [Related]
70. Soluble CD95 in the serum of patients with low and intermediate grade malignant lymphomas: absence of prognostic correlations.
Munker R; Younes A; Cabanillas F; Andreeff M
Leuk Lymphoma; 1997 Nov; 27(5-6):517-21. PubMed ID: 9477134
[TBL] [Abstract][Full Text] [Related]
71. Soluble CD40 ligand derived from serum is not correlated with early MS.
Zahednasab H; Siroos B; Balood M; Aleagha MSE; Harirchian MH
Mult Scler Relat Disord; 2017 May; 14():29-31. PubMed ID: 28619427
[TBL] [Abstract][Full Text] [Related]
72. Clinical Significance of Circulating Serum Levels of sCD95 and TNF-α in Cytoprotection of Cervical Cancer.
Agnihotri SK; Kumar B; Jain A; Anjali A; Negi MPS; Sachan R; Bhatt MLB; Tripathi RK; Sachdev M
Rep Biochem Mol Biol; 2022 Jan; 10(4):711-721. PubMed ID: 35291617
[TBL] [Abstract][Full Text] [Related]
73. Reference intervals of serum soluble APO-1 (Fas/CD95) concentrations in healthy adults.
Choi JW
Ann Clin Lab Sci; 2006; 36(1):103-4. PubMed ID: 16501245
[No Abstract] [Full Text] [Related]
74. Hormonal and gender-related immune changes in multiple sclerosis.
Airas L
Acta Neurol Scand; 2015; 132(199):62-70. PubMed ID: 26046561
[TBL] [Abstract][Full Text] [Related]
75. Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy.
Rossi C; Cicalini I; Zucchelli M; di Ioia M; Onofrj M; Federici L; Del Boccio P; Pieragostino D
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30441762
[TBL] [Abstract][Full Text] [Related]
76. Serum Glutamate Is a Predictor for the Diagnosis of Multiple Sclerosis.
Al Gawwam G; Sharquie IK
ScientificWorldJournal; 2017; 2017():9320802. PubMed ID: 28676865
[TBL] [Abstract][Full Text] [Related]
77. Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy.
Papapavlou Lingehed G; Hellberg S; Huang J; Khademi M; Kockum I; Carlsson H; Tjernberg I; Svenvik M; Lind J; Blomberg M; Vrethem M; Mellergård J; Gustafsson M; Jenmalm MC; Olsson T; Ernerudh J
Front Immunol; 2022; 13():930947. PubMed ID: 35967338
[TBL] [Abstract][Full Text] [Related]
78. [Multiple sclerosis and pregnancy].
RUSZ S
Ideggyogy Sz; 1958; 11(1-2):35-41. PubMed ID: 13574806
[No Abstract] [Full Text] [Related]
79. [Multiple sclerosis & pregnancy. II].
SPRENGER EH
Geneeskd Gids; 1957 Sep; 35(19):319-25 concl. PubMed ID: 13474256
[No Abstract] [Full Text] [Related]
80. [Multiple sclerosis & pregnancy].
SPRENGER EH
Geneeskd Gids; 1957 Aug; 35(18):308-11 contd. PubMed ID: 13474255
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
